Fig. 2: Prognostic roles of NGS-MRD at pre-HSCT and post-HSCT. | Blood Cancer Journal

Fig. 2: Prognostic roles of NGS-MRD at pre-HSCT and post-HSCT.

From: Prognostic value of measurable residual disease monitoring by next-generation sequencing before and after allogeneic hematopoietic cell transplantation in acute myeloid leukemia

Fig. 2

a Cumulative incidence of relapse and overall survival according to NGS-MRD status at pre-HSCT and post-HSCT-1m. b–d Prognostic effect of changes in NGS-MRD status between pre-HSCT and post-HSCT-1m. b NGS-MRD status at pre-HSCT and post-HSCT-1m. c Outcomes in the three groups classified by changes in NGS-MRD status between pre-HSCT and post-HSCT-1m. d Survival outcomes in the three groups classified by changes in NGS-MRD status between pre-HSCT and post-HSCT-1m.

Back to article page